We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
American Century US Quality Growth ETF
QGRO
$1.92B
| $781K | ﹤0.01% |
+6,617
| New | +$751K |
2026 Q2
0 quarters
|
|
2302
BioAge Labs
BIOA
$229M
| $778K | ﹤0.01% |
31,743
-158,729
| -83% | -$2.87M |
2025 Q1
5 quarters
|
|
2303
Ginkgo Bioworks
DNA
$675M
| $772K | ﹤0.01% |
+77,937
| New | +$652K |
2026 Q2
0 quarters
|
|
2304
Employers Holdings
EIG
$934M
| $772K | ﹤0.01% |
+15,300
| New | +$671K |
2026 Q2
0 quarters
|
|
2305
EuroDry
EDRY
$143M
| $770K | ﹤0.01% |
35,176
+24,370
| +226% | +$527K |
2026 Q1
1 quarter
|
|
2306
Hovnanian Enterprises
HOV
$590M
| $769K | ﹤0.01% |
5,400
| – | – |
2024 Q1
9 quarters
|
|
2307
Carpenter Technology
CRS
$14.3B
| $765K | ﹤0.01% |
1,240
-9,831
| -89% | -$4.63M |
2026 Q1
1 quarter
|
|
2308
Archer Aviation
ACHR
$3.03B
| $763K | ﹤0.01% |
161,368
-2,094,804
| -93% | -$12.2M |
2025 Q1
5 quarters
|
|
2309
GrabAGun Digital Holdings
PEW
$60.5M
| $763K | ﹤0.01% |
334,650
+257,159
| +332% | +$713K |
2025 Q4
2 quarters
|
|
2310
New Fortress Energy
NFE
$19M
| $760K | ﹤0.01% |
42,201
-13,639
| -24% | -$406K |
2024 Q4
6 quarters
|
|
2311
Redwood Trust
RWT
$406M
| $755K | ﹤0.01% |
159,384
+126,687
| +387% | +$688K |
2026 Q1
1 quarter
|
|
2312
Invesco KBW Bank ETF
KBWB
$6.27B
| $755K | ﹤0.01% |
+8,120
| New | +$710K |
2026 Q2
0 quarters
|
|
2313
Carter Bankshares
CARE
$715M
| $752K | ﹤0.01% |
+22,118
| New | +$599K |
2026 Q2
0 quarters
|
|
2314
iShares US Aerospace & Defense ETF
ITA
$12.1B
| $752K | ﹤0.01% |
+3,100
| New | +$706K |
2026 Q2
0 quarters
|
|
2315
Coca-Cola Europacific Partners
CCEP
$49.3B
| $749K | ﹤0.01% |
7,464
-61,174
| -89% | -$5.83M |
2025 Q4
2 quarters
|
|
2316
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.09B
| $749K | ﹤0.01% |
+10,900
| New | +$728K |
2026 Q2
0 quarters
|
|
2317
Timberland Bancorp
TSBK
$365M
| $745K | ﹤0.01% |
16,617
+11,362
| +216% | +$470K |
2026 Q1
1 quarter
|
|
2318
Corbus Pharmaceuticals
CRBP
$77.2M
| $744K | ﹤0.01% |
79,331
-67,265
| -46% | -$637K |
2025 Q2
4 quarters
|
|
|
SA
2319
Seabridge Gold
SA
$2.76B
| $739K | ﹤0.01% |
28,720
+18,169
| +172% | +$546K |
2024 Q2
8 quarters
|
|
2320
Kennametal
KMT
$2.27B
| $738K | ﹤0.01% |
21,067
+15,458
| +276% | +$563K |
2025 Q3
3 quarters
|
|
2321
ZKH Group
ZKH
$281M
| $738K | ﹤0.01% |
+326,472
| New | +$941K |
2026 Q2
0 quarters
|
|
2322
Compass Therapeutics
CMPX
$135M
| $733K | ﹤0.01% |
+334,869
| New | +$989K |
2026 Q2
0 quarters
|
|
2323
Grandstand Ltd
GRSD
$41.6M
| $732K | ﹤0.01% |
+385,149
| New | +$1.2M |
2026 Q2
0 quarters
|
|
2324
OnKure Therapeutics
OKUR
$100M
| $729K | ﹤0.01% |
159,881
+123,437
| +339% | +$530K |
2026 Q1
1 quarter
|
|
2325
Ingles Markets
IMKTA
$1.66B
| $728K | ﹤0.01% |
8,214
-23,084
| -74% | -$2.06M |
2026 Q1
1 quarter
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.